It has been suggested that breathing circuits contaminated with body fluids may provide a route of nosocomial patient-to-patient transmission of the hepatitis C virus. Thus, a number of authorities have recommended the use of breathing circuit filters to minimize such risks. The present study sought to simulate a humidified breathing circuit and evaluate two different designs of breathing circuit filters to determine their efficacy in preventing passage of the hepatitis C virus. A hydrophobic pleated-membrane filter consistently prevented the passage of hepatitis C virus while a large-pore "electret" filter design was ineffective. We conclude that not all filter types are equally suited to preventing the passage of viruses and we therefore consider it essential that, if filters are intended to prevent the passage of named pathogens in a humidified breathing circuit, they should be evaluated in a similar experimental system to that described in order to prove their efficacy.
Hepatitis C virus (HCV) is a member of the flavivirus family and is a small single-stranded RNA virus 30-38 nm in diameter with a lipoid envelope 1 . The hepatitis C genome was isolated and cloned in 1988, and was recognized to be the cause of most cases (>90%) of non-A, non-B hepatitis 1, 2 . The prevalence of HCV varies considerably, both between geographic regions and within community groups. Within most western countries the prevalence is between 0.3 and 1.2% of the population, being 0.3% in Australian blood donors 3 . However, among regular intravenous drug abusers the prevalence can be in excess of 90% 4 . Once acquired, the infection is chronic in more than 60% of infected persons, and may progress to hepatic cirrhosis with its related complications and high incidence of hepatocellular carcinoma 5 .
Nosocomial patient-to-patient transmission of HCV is well documented 6 and is particularly prevalent in chronic haemodialysis patients (24% of patients in one study) 7 . Surgeon-to-patient transmission has also been documented 8 . An interesting series of cases of patient-to-patient transmission, occurring during a minor surgical list, has been investigated in great detail 9 . All patients were found to be infected with HCV genotype 1a and careful investigation did not reveal any obvious percutaneous risks for infection. While the mode of transmission cannot be conclusively established, some features of the transmission implicated contamination of the anaesthetic circuit.
It was suggested that the index case in this transmission series introduced infected respiratory secretions and/or blood into the reusable part of the anaesthetic circuit which was the source of infection for the other patients. Despite there being a local infection control policy advocating the use of airway filters, none was used on this occasion. The present study was designed to assess and compare the ability of two different filter types to prevent the transfer of HCV using a test system simulating a breathing circuit.
MATERIALS AND METHODS

Filter and Ventilator Circuit
The study involved the use of two types of airway filter: 1. a pleated hydrophobic (liquid-tight) breathing system filter (Pall BB22-15 Breathing System Filter, Pall Europe Ltd, Portsmouth, U.K.), and 2. an "electret" filter incorporating a native felt-like material having been subjected to an electric field, producing a felt with high polarity (Intersurgical 1942 Filtatherm HME Filter, Intersurgical Ltd, Workingham, U.K.). All filters used in the study were prepared as shown in Figure 1 , prior to conditioning. A sampling tube (Steriflex Intravenous Catheter, Vygon) was inserted each side of the filter housing. Diluent (5 ml) was introduced to each side of the filter housing via the sample tubes. The diluent used was either phosphate buffered saline pH7.2 (PBS) or artificial saliva (Pharmaceutical Unit, St. Mary's Hospital, Penarth). PBS or artificial saliva was placed on the non-patient side of the filter to act as a collection medium for the virus.
Filters were conditioned for 23.5 hours in a circuit shown in Figure 2 . The ventilator (Ohmeda OAV 7710) was operated at a rate of 14.3 cycles/minute with a flow rate of 10 litres/minute, I/E ratio 1:2, tidal volume of 0.7 litres through each filter, at a mean temperature of 35±1°C. Relative humidity was maintained at >90% by a Pearl Humidifier 4250 (Kontron Instruments).
Viral Challenge and Sampling
200 µl of HCV positive serum (2.0 x 10 5 HCV genome equivalents) was introduced to the filter housing via sampling port A (Figure1). The tube was flushed with 500 µl phosphate buffered saline (PBS), resulting in a final HCV concentration of 4.0 x 10 4 HCV genome equivalents/ml. Air was passed through the filter for five minutes using a resuscitation bag (unidirectional flow). The resuscitation bag was introduced at this stage in order to prevent the contamination of the ventilator. There was no technical reason to suggest that similar results would not have been achieved with the ventilator. All aspects of these procedures were carried out at an ACDP containment level 3 laboratory, within a Class III biosafety cabinet.
After the period of manual ventilation the diluent/collection medium was removed via the sample ports A and B, aliquoted and a sample taken for assessment. The remainder was stored at -70°C.
HCV Assays
The presence of HCV within samples was determined by the use of the qualitative "Amplicor" HCV test (Roche Diagnostic Systems) according to the manufacturer's instructions. This is based on viral nucleic acid amplification by reverse transcriptasepolymerase chain reaction (RT-PCR). Artificial saliva and PBS inoculated with HCV positive serum at 1:100 dilution were included as additional positive controls and to determine if the diluents had any effect on the test assay.
The presence of HCV was determined by comparing the absorbency of the unknown specimens to that of positive and negative controls. • Samples with an A450 reading <0.300 were interpreted as negative. • Samples with an A450 reading >0.500 were interpreted as positive. • Samples with an A450 result between 0.300 and 0.500 would have been considered equivocal and retested. However, no result was recorded within this range. The viral load in the serum used as the HCV source was determined using the quantitative RT-PCR-based "Monitor" assay (Roche Diagnostic Systems) as per the manufacturer's instructions. 
Statistical Analysis
Results were compared using a 2x2 contingency table and the χ 2 test corrected for continuity.
RESULTS
The data obtained in this study is summarized in Table 1 . No evidence of HCV was found on the exhaust side of the pleated hydrophobic filters (n=7), either with artificial saliva or PBS as diluent. Evidence of HCV on the exhaust side was found with all the electret filters tested (n=7)(χ 2 =14, P=0.0013) with both the PBS and artificial saliva. Samples of PBS (n=8) or artificial saliva (n=8) spiked with the HCV serum at a 1:100 dilution were all RT-PCR positive.
DISCUSSION
Breathing circuits used in the settings of anaesthesia and intensive care units represent a risk of nosocomial infection. In routine anaesthetic practice several patients may share the same breathing circuit if specific precautions are not taken. Two potential sources of contamination exist. Firstly, contamination due to secretions can occur in the airways proximal to the patient. More extensive potential contamination may occur due to partial rebreathing, especially in circle systems and with low fresh gas flows. Possible solutions to minimize patient-to-patient infection include complete replacement of the circuit between cases or the introduction of mechanical barriers such as filters.
A recent report 9 has generated considerable debate as to whether respiratory secretions, saliva, or secretions contaminated with blood could contaminate breathing system tubing and allow for patient-topatient transmission of HCV to occur. It seems plausible that laryngoscopy itself or airway devices, such as endotracheal tubes and laryngeal masks, could cause tracheal, laryngeal or pharyngeal abrasion and bleeding, increasing the risk of spread of blood-borne pathogens. It has been shown that HCV RNA can be found in saliva of HCV seropositive patients 10 . Moreover, HCV RNA was detected in serum from a recipient chimpanzee inoculated with HCV RNA positive saliva 11 . It has been reported that other viruses remain viable and can be isolated from saliva, such as human herpes virus 6 12 . Additionally, hepatitis B has been transmitted by human bite 13 .
In the United Kingdom, it has been suggested by the Joint Working Party of the Hospital Infection Society and the Surgical Infection Study Group 14 that all operating theatres should have a policy on precautions against the risk of HIV (and hepatitis) transmission, which should be based on local assessment. For anaesthetic systems a suggestion made by the authors was that: "… heat and moisture exchangers with good filtration properties could be used and the filters changed between cases". More recently, a report by the Blood Borne Viruses Advisory Panel of the Association of Anaesthetists of Great Britain and Ireland 15 discusses various hygienic options for anaesthesia. The group recommended to Council "... either an appropriate filter should be placed between the patient and the breathing system, a new filter being used for each patient or that a new breathing system be used for each patient …". They also commented "of the filters currently available, only those which use a pleated, hydrophobic membrane reliably prevent contamination of the breathing system". The New South Wales (Australia) Health Department Infection Control Policy (Circular 95/13)(10a) outlines the following procedures to be adopted by anaesthetists:
I. If the breathing circuit uses a filter, the filter must be discarded after each patient. II. That part of the breathing circuit between the patient and the filter must be discarded, or cleaned and disinfected, after each patient. III. That part of the breathing circuit between the carbon dioxide absorber and the filter must be discarded, or cleaned and disinfected at the end of each procedure list. IV. If the breathing circuit does not use a filter the breathing circuit must be discarded, or cleaned and disinfected after each patient. These guidelines highlight that there is significant concern in relation to risks of nosocomial infection via anaesthetic equipment. One editorial has reviewed the case of Hygiene Standards for Breathing Systems 16 . The author highlighted that for many years it has been known that breathing systems can become contaminated and act as a reservoir for a wide variety of micro-organisms, especially if there is moisture present and suggested that "… filters provide some measure of protection in such circumstances". A further editorial 17 proposed that filters be placed 237 BREATHING FILTERS AND HEPATITIS C Anaesthesia and Intensive Care, Vol. 25, No. 3, June 1997 between the catheter mount and the breathing system to prevent contamination with bacteria and viruses. The article also observed that not all filters were equally effective and depended upon the design of the filter and hydrophobicity of its components.
There are two main geometries of airway filter currently marketed; the pleated hydrophobic membrane filters and the "electret" type made of electrostatically charged felt material. The physical characteristics of filters are described in terms of their hydrophobicity, pore size, surface area, and membrane thickness. Other features relevant to clinical use include deadspace, resistance to gas flow (dry and moist), as well as filtration efficiency. The pleated membrane filters tested are composed of hydrophobic resin coated ceramic filaments, giving a very small pore size. The construction gives a thin membrane, pleated to give a large surface area delivering water tightness and resistance to passage of saliva and other body fluids 18 . In contrast, "electret" filters are constructed of a thick flat "felt-like" layer with a low surface area and large pore size, allowing liquid to pass through. This can result in contamination of the machine side of the device and associated equipment [18] [19] [20] , within short time periods.
The inclusion of an "electret" filter into the test procedure was to demonstrate that the test method used was capable of detecting penetration of the contaminated "secretions". This was based on previous studies demonstrating penetration of contaminated liquids through this type of device (Faber and Wille) 19 . This reference suggests that all "electret" devices would behave in a similar manner.
Under the test conditions used in the present study, the results show that the pleated hydrophobic filter provided a barrier to the passage of HCV. A large pore electret filter did not provide a barrier to the passage of HCV. We therefore consider it essential that, if filters are intended to prevent the passage of named pathogens in a humidified breathing circuit, they should be evaluated in a similar experimental system to that described in order to prove their efficacy.
